• Cancer: Sialylation of the epidermal gro

    From ScienceDaily@1:317/3 to All on Fri Apr 22 22:30:48 2022
    Cancer: Sialylation of the epidermal growth factor receptor modulates
    cell mechanics and enhances invasion

    Date:
    April 22, 2022
    Source:
    University of Alabama at Birmingham
    Summary:
    In a study that included tests of three types of human cancer
    cells, researchers report that ST6Gal-I--mediated sialylation of
    the epidermal growth factor receptor modulates cell mechanics and
    enhances invasion by the cancer cells.



    FULL STORY ==========================================================================
    For more than two decades, University of Alabama at Birmingham researcher
    Susan Bellis, Ph.D., has studied how the addition of sialic acid to
    various proteins increases cancer resistance and oncogenicity.


    ==========================================================================
    One of the enzymes that transfers sialic acid to target glycoproteins is ST6Gal-I, and it has attracted increased attention in the cancer field
    in recent years. ST6Gal-I is upregulated in breast cancer, gliomas,
    pancreatic cancer, prostate cancer and ovarian cancer, and it plays a
    key role in tumor progression and metastasis.

    Metastasis is the spread of a tumor to other parts of the body, through
    the migration of tumor cells. Cells move themselves through cell adhesion mechanics -- integrins at the cell membrane can attach themselves to
    a surface, acting as tiny anchors. The cell's cytoskeleton then pushes
    the front of the cell forward to establish new anchors, and the now-rear anchors let go. Such cell mobility is vital in embryogenesis, development
    and wound healing. However, in cancer, cell migration can be deadly.

    UAB researcher Alexa Mattheyses, Ph.D., is able to study cell adhesion mechanics directly, using DNA tension-gauge tether probes displaying an integrin ligand and attached to a coverslip surface. When a cell binds to
    the tension probe and exerts force, the DNA duplex separates, generating
    a fluorescent signal whose changes are monitored by sophisticated
    fluorescence microscopy. Two years ago, the Mattheyses lab showed that activation of the epidermal growth factor receptor, or EGFR, by its ligand
    -- epidermal growth factor, or EGF -- modulated integrin forces and
    attenuated the mechanical threshold for integrin tension and formation
    of focal adhesions. Focal adhesions are the mechanical linkages, the
    anchors, to the extracellular matrix outside the cell. They are also the
    place where mechanical force and regulatory signals are transmitted. A cell-surface receptor like EGFR transfers a signal from its external
    ligand to the interior of the cell.

    The Mattheyses and Bellis labs collaborated to expand their EGFR
    work by looking at the effect of adding sialic acid to EGFR on cell
    mechanics. In a study published in theJournal of Biological Chemistry
    that included tests of three types of human cancer cells, they report
    that ST6Gal-I-mediated sialylation of the EGFR modulates cell mechanics
    and enhances invasion by the cancer cells.

    "Given the widespread impact of sialylation and the prognostic
    value of ST6Gal- I expression, an improved understanding of how ST6Gal-I-mediated sialylation alters cell mechanics may open the door
    to a new range of cancer therapeutics," Mattheyses said. "Our results
    help bridge the mechanistic gap in the field, while demonstrating the
    potential value in oncogenic mechanosignaling as a therapeutic target." "Clinically, increased glycoprotein sialylation has been associated with carcinogenesis, and ST6Gal-I promotes vital cancer hallmarks such as self- renewal, invasiveness, proliferative potential and resistance to cell
    death," Mattheyses said. "While mechanical changes in cells and tissues
    also contribute to malignancy and metastasis, the underlying mechanisms
    by which these changes promote cancer have remained understudied."


    ==========================================================================
    The UAB researchers used primate kidney cells as a test-bed system,
    and three types of human cancer cells. In cells with little or no
    ST6Gal-I, they introduced and overexpressed the enzyme. In cells that
    expressed ST6Gal-I, they knocked down expression. They then compared overexpressing and poorly expressing cells, using DNA tension-gauge
    tethers and fluorescence microscopy.

    They found that ST6Gal-I overexpression promoted cell spreading and focal adhesion maturation in an activated EGFR-dependent manner. The cells'
    force histories, as reported by the DNA tethers, showed that ST6Gal-I overexpression led to increased tension generation by integrins. Classical cancer biology assays showed that ST6Gal-I overexpression enhanced mechanosignaling-increased migration, invasion, proliferation and
    survival.

    The researchers also examined the downstream EGFR-signaling cascades that
    might regulate mechanical outcomes or alterations in cell morphometrics,
    which is the quantitative analysis of form. They found that changes in
    cell mechanical properties -- such as integrin tension, focal adhesion nucleation and promotion of cell spread area -- depended on the extracellular-signal-regulated kinase, or ERK, pathway. In contrast,
    increases in cellular migration, invasion, proliferation and survival
    were controlled via the phosphoinositide 3-kinase- Akt serine/threonine
    kinase, or AKT, cascade.

    They also found that high ST6Gal-I activity led to sustained EGFR membrane retention, making it a key regulator of cell mechanics.

    "Our findings suggest a novel sialylation-dependent mechanism
    orchestrating cellular mechanics and enhancing cell motility via EGFR signaling," Mattheyses said.

    Mattheyses and Bellis are associate professor and professor, respectively,
    in the UAB Department of Cell, Developmental and Integrative Biology,
    in the Marnix E. Heersink School of Medicine. At UAB, Bellis holds the
    Alma B.

    Maxwell-UAHSF Endowed Chair in Biomedical Research. Bellis is a senior scientist and Mattheyses a scientist in the O'Neal Comprehensive Cancer
    Center at UAB, and Mattheyses also directs the center's Microscopy
    Shared Resource.

    Co-authors with Mattheyses and Bellis are Tejeshwar C. Rao, Reena
    R. Beggs, Katherine E. Ankenbauer and Jihye Hwang, UAB Department of Cell, Developmental and Integrative Biology; and Victor Pui-Yan Ma and Khalid Salaita, Emory University, Atlanta, Georgia.

    Support came from National Science Foundation CAREER grant 1832100; and
    from National Institutes of Health grants GM131099, CA233581, CA225177, CA223074 and CA013148.


    ========================================================================== Story Source: Materials provided by
    University_of_Alabama_at_Birmingham. Original written by Jeff
    Hansen. Note: Content may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Tejeshwar C. Rao, Reena R. Beggs, Katherine E. Ankenbauer,
    Jihye Hwang,
    Victor Pui-Yan Ma, Khalid Salaita, Susan L. Bellis, Alexa
    L. Mattheyses.

    ST6Gal-I-mediated sialylation of the epidermal growth factor
    receptor modulates cell mechanics and enhances invasion. Journal
    of Biological Chemistry, 2022; 298 (4): 101726 DOI:
    10.1016/j.jbc.2022.101726 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2022/04/220422114737.htm

    --- up 7 weeks, 4 days, 10 hours, 51 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)